Denise Carter

COO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

QNRX

Current role

COO, Board Member

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Quoin Pharmaceuticals Ltd. (QNRX)	Chief Operating Officer Sally Lawlor Chief Financial Officer	$595,440	—	—	$331,285	$297,720	$57,840	$1,282,285
2024	Quoin Pharmaceuticals Ltd. (QNRX)	Chief Operating Officer	$529,980	$264,640	—	$353,017	—	$63,625	$1,211,262
2023	Quoin Pharmaceuticals Ltd. (QNRX)	Chief Operating Officer	$481,800	$240,900	—	$292,266	—	$56,000	$1,070,966
2022	Quoin Pharmaceuticals Ltd. (QNRX)	Chief Operating Officer	$440,000	$198,000	—	$1,112,187	—	$55,215	$1,805,402

Earnings-call appearances and filed executive appointments or departures, newest first.